Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
Recruiting
Observational Study
Takayasu Arteritis
Takayasu Arteritis (TAK)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- University of Edinburgh · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
For the patient questionnaire:
* Age ≥ 18 years
* A formal diagnosis of TAK
For the physician questionnaire
• A physician involved in the management/decision-making for patients diagnosed with TAK
Exclusion Criteria:
For the patient questionnaire:
* Age \< 18 years
* Lack …
Contacts